Dangerous kratom drug interactions: what to know about mixing

Kratom rarely causes fatal overdose on its own. The deaths are almost always polysubstance. A 2019 CDC analysis of kratom-detected overdose deaths in 27 states found that of 91 deaths where kratom appeared on postmortem toxicology, all but seven involved documented exposure to other substances. The same pattern has been documented in subsequent analyses.

The reason is pharmacological. Kratom's partial-agonist ceiling limits the respiratory depression it can cause alone. Remove that ceiling, by adding benzodiazepines, alcohol, full opioids, or other CNS depressants, and the picture changes significantly. Add a concentrated 7-OH product instead of leaf, and the ceiling largely disappears on its own.

This page covers the key interactions, the two mechanisms that drive them, and what to do if someone is in trouble.

At a glance: kratom drug interactions

Combined withWhy it is dangerous
Benzodiazepines (Xanax, Valium, Klonopin, Ativan)Synergistic CNS and respiratory depression; one of the deadliest combinations documented in kratom deaths
AlcoholAdditive CNS depression; impairs judgment about further dosing; present in fatal 7-OH overdose cases
Other opioids (fentanyl, oxycodone, heroin)Stacked opioid receptor activity; fentanyl is the most common co-ingestant in kratom overdose deaths
SSRIs, SNRIs, MAOIs, other antidepressantsSerotonin syndrome risk via dual mechanism; see full deep-dive at the link below
Gabapentinoids (gabapentin, pregabalin)Additional CNS depression stacking; gabapentin is associated with opioid overdose deaths independently
Sedating antihistamines (diphenhydramine)More CNS depression; often underestimated because of OTC availability
Tramadol, tapentadolOpioid activity plus serotonergic activity; dual interaction risk

Key Takeaways

  • Most kratom overdose deaths involve other substances. The 2019 CDC SUDORS analysis found the large majority of kratom-detected overdose deaths involved documented polysubstance exposure.
  • Two mechanisms drive interaction risk. Kratom stacks central-nervous-system depression with other sedatives, and it inhibits liver enzymes that metabolize many medications, raising their blood levels.
  • Benzodiazepines and alcohol are the highest-risk combinations for respiratory depression. Antidepressants carry a separate serotonin-syndrome risk.
  • Concentrated 7-OH substantially raises the stakes. Its higher opioid receptor potency reduces the partial-agonist ceiling that makes leaf-alone overdose less common.
  • Do not stop a prescribed medication on your own. Kratom is the risky addition. Talk to your prescriber, and call 911 for any overdose.

Why mixing is so dangerous: two mechanisms

Mechanism 1: Additive and synergistic CNS depression. Kratom acts on mu-opioid receptors, producing sedation and respiratory depression as part of its opioid-like effect. Any other substance that also depresses the central nervous system adds to that effect. Benzodiazepines, alcohol, full opioids, gabapentinoids, and sedating antihistamines all work through different receptor systems, but they converge on the same outcome: slowed breathing. When multiple CNS depressants are on board simultaneously, the combined effect is greater than what any individual substance would produce alone.

This is why the FDA carries a serious boxed warning about combining opioids with benzodiazepines, specifically noting that the combination can result in profound sedation, respiratory depression, coma, and death.

Mechanism 2: CYP enzyme inhibition. Kratom alkaloids inhibit cytochrome P450 liver enzymes, particularly CYP2D6 and CYP3A4. These enzymes metabolize a large number of prescription medications. When they are inhibited, co-administered medications clear from the body more slowly, and blood levels can accumulate above what the prescribed dose was intended to produce.

This pharmacokinetic interaction affects benzodiazepines, many antidepressants, some antipsychotics, certain cardiac medications, and others. The practical result: someone taking a stable prescription dose of a CYP2D6-metabolized medication adds kratom and inadvertently raises their drug exposure.

MechanismWhat it doesWhich substances are affected
Additive CNS depressionCompounds respiratory depression from multiple directionsBenzodiazepines, alcohol, opioids, gabapentinoids, sedating antihistamines
CYP enzyme inhibitionRaises blood levels of co-administered drugsSSRIs, SNRIs, benzodiazepines, some opioids, other CYP2D6/3A4 substrates

Benzodiazepines: the deadliest combination

Benzodiazepines, prescribed for anxiety, panic disorder, and sleep (including alprazolam/Xanax, diazepam/Valium, lorazepam/Ativan, and clonazepam/Klonopin), and kratom are both central nervous system depressants. Together, they produce synergistic respiratory depression, meaning the combined effect on breathing is greater than additive.

The CDC SUDORS analysis documented benzodiazepines as one of the most commonly co-occurring substances in kratom-detected overdose deaths. The combination is dangerous for two reasons working together: the direct pharmacodynamic synergy on breathing, and the fact that many benzodiazepines are metabolized by CYP enzymes that kratom inhibits, which can push benzo levels higher than the prescribed dose is intended to reach.

A common scenario is timing-based: someone takes kratom for pain or energy during the day, and then their prescribed benzodiazepine later, not realizing that kratom is still pharmacologically active and that its CYP inhibition has already begun affecting the benzo's clearance. The combination can produce profound sedation and respiratory failure even when each substance was taken at doses that seemed individually reasonable.

Critical caveat about benzodiazepines: do not stop a prescribed benzodiazepine abruptly. Abrupt benzodiazepine discontinuation can cause seizures and is medically dangerous. Kratom is the risky addition to this combination. If you are concerned about combining kratom with a prescribed benzodiazepine, speak with your prescriber.

Alcohol

Alcohol and kratom is a combination that appears in fatal concentrated 7-OH overdose cases and is likely underestimated because alcohol is so socially normalized that people do not categorize it as a drug combination.

Alcohol is a CNS depressant operating through its own receptor mechanisms. It adds to kratom's depression of respiratory drive, reduces inhibitions about dosing more, and impairs the person's ability to recognize that they are becoming dangerously sedated. The combination of high-potency 7-OH and alcohol has been documented in overdose deaths by county medical examiners.

Other opioids: fentanyl is the most common co-ingestant

Combining kratom with other opioids stacks opioid receptor activity directly. In the current illicit drug supply, fentanyl is the most common co-ingestant in kratom-related deaths. This reflects the broader contamination of the drug supply: people buying unregulated kratom products, particularly concentrated 7-OH extracts, may be exposed to fentanyl contamination without knowing it. A product test that showed only 7-OH on the label may contain actual fentanyl.

Full opioids like heroin, oxycodone, or fentanyl combined with kratom remove the partial-agonist ceiling that limits leaf kratom's respiratory depression. The result is classical opioid overdose pharmacology without any of the margin that kratom's partial agonism might otherwise provide.

Gabapentinoids and sedating antihistamines

Gabapentin and pregabalin (Lyrica) are increasingly common co-ingestants in overdose deaths. A CDC SUDORS analysis of gabapentin-involved overdose deaths found that the combination with opioids independently raises respiratory depression risk. Because kratom acts on opioid receptors, the same dynamic applies.

Sedating antihistamines like diphenhydramine (Benadryl) are available over the counter and often not recognized as contributing to CNS depression when combined with kratom or 7-OH. Stacking multiple depressants, even relatively mild ones, raises the cumulative risk of respiratory failure.

SSRIs, SNRIs, and antidepressants: serotonin syndrome

Combining kratom with antidepressants raises a different interaction risk: serotonin syndrome, caused by excess serotonergic activity. Kratom adds its own serotonergic effects and inhibits the enzymes that clear many antidepressants. Published case reports document serotonin syndrome in patients using kratom alongside prescribed SSRIs and other serotonergic medications.

Serotonin syndrome ranges from mild (tremor, agitation, rapid heart rate) to life-threatening (high fever, muscle rigidity, confusion). If you are using kratom alongside any antidepressant, tell your prescriber. Do not stop your antidepressant on your own.

For the full clinical picture, see Kratom and Antidepressants: The Serotonin Syndrome Risk Nobody Mentions.

Warning signs and what to do in an overdose

Signs of opioid or CNS depressant overdose:

  • Very slow, shallow, or stopped breathing
  • Extreme drowsiness or unresponsiveness; cannot be woken
  • Gurgling or choking sounds
  • Blue or gray color to lips, fingernails, or skin (cyanosis)
  • Pinpoint (very small) pupils
  • Limp body

If you see these signs:

  1. Call 911 immediately. Do not wait.
  2. Tell responders exactly what was taken and when, including kratom, any prescription medications, alcohol, and any other substances.
  3. If the person is unconscious but breathing, place them on their side to prevent aspiration.
  4. Administer naloxone (Narcan) if available.

The naloxone caveat for polysubstance situations: naloxone reverses the opioid component of kratom and 7-OH respiratory depression. It does NOT reverse benzodiazepines or alcohol. In a mixed overdose, naloxone may partially improve breathing without fully resolving the overdose. Because 7-OH also has a longer half-life than naloxone, a single dose may wear off before the 7-OH does, causing breathing to slow again. Repeat doses may be needed. Always call 911 even after giving naloxone, even if the person appears to wake up.

If kratom has become hard to stop

Many people using kratom alongside other substances started with one substance and gradually added others as tolerance developed or symptoms changed. If stopping kratom, or reducing use, has become difficult alongside managing other prescriptions, a clinician can help assess the full picture safely. Buprenorphine/naloxone is effective for kratom and 7-OH dependence and is accessible through telehealth in most states. Learn how Bicycle Health's treatment works.

Frequently Asked Questions

Is it safe to mix kratom with Xanax?

No. Kratom and alprazolam (Xanax) are both CNS depressants, and their combination produces synergistic respiratory depression. Kratom also inhibits CYP enzymes that metabolize many benzodiazepines, which can raise alprazolam blood levels above what the prescribed dose intended. This combination has been documented in fatal overdose cases. If you are taking a prescribed benzodiazepine and also using kratom, speak with your prescriber. Do not stop your benzodiazepine on your own.

Can you drink alcohol while using kratom?

Combining alcohol with kratom or concentrated 7-OH adds additional CNS depression to kratom's opioid-like respiratory effects. The combination has been documented in fatal overdose cases involving concentrated 7-OH. Alcohol is pharmacologically a CNS depressant regardless of its social status, and the combination with kratom or 7-OH carries real risk of respiratory failure, particularly at higher doses.

Why are most kratom overdose deaths polysubstance?

Kratom leaf's partial-agonist pharmacology produces a ceiling effect that limits respiratory depression from the substance alone. That ceiling is significantly reduced by adding other CNS depressants, which multiply the respiratory depression effect. Concentrated 7-OH reduces that ceiling substantially on its own; when combined with other depressants, the risk of fatal respiratory depression approaches that of classical opioids.

Does naloxone work for kratom overdose?

Yes, but with important limitations in polysubstance situations. Naloxone reverses the opioid-receptor component of kratom and 7-OH respiratory depression. It does not reverse benzodiazepines or alcohol. In mixed overdoses, naloxone may partially improve breathing without resolving all of the respiratory depression. Additionally, 7-OH can outlast a single naloxone dose, causing breathing to slow again after the naloxone wears off. Always call 911 before or immediately after giving naloxone.

Can I take kratom with gabapentin?

Gabapentin is a CNS depressant independently associated with elevated opioid overdose risk. Combining it with kratom stacks CNS depression and raises the risk of respiratory failure. CDC data show gabapentin is present in a meaningful percentage of overdose deaths involving opioid-acting substances. If you are taking prescribed gabapentin and also using kratom, your prescriber should know.

Get help safely if kratom has become hard to stop

Telehealth treatment is available for kratom and 7-OH dependence in most states.

If someone is overdosing, call 911 immediately. Administer naloxone if available and stay until help arrives. SAMHSA's free helpline: 1-800-662-4357, available 24/7. This article is for general health information only and is not a substitute for medical advice. Do not stop any prescribed medication without guidance from your prescriber.

Next Steps

Sources

  1. Olsen EO, O'Donnell J, Mattson CL, Schier JG, Wilson N. Notes from the field: unintentional drug overdose deaths with kratom detected — 27 states, July 2016 – December 2017. MMWR Morb Mortal Wkly Rep. 2019;68(14):326-327. doi:10.15585/mmwr.mm6814a2. https://www.cdc.gov/mmwr/volumes/68/wr/pdfs/mm6814a2-H.pdf
  2. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. FDA; August 31, 2016. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or
  3. Eudaley ST, Brooks SP, Hamilton LA. Case report: possible serotonin syndrome in a patient taking kratom and multiple serotonergic agents. Journal of Pharmacy Practice. 2023;36(6):1523-1527. doi:10.1177/08971900221116009. PMID: 35840540. https://pubmed.ncbi.nlm.nih.gov/35840540/
  4. Brogdon HD, McPhee MM, Paine MF, Cox EJ, Burns AG. A case of potential pharmacokinetic kratom-drug interactions resulting in toxicity and subsequent treatment of kratom use disorder with buprenorphine/naloxone. Journal of Addiction Medicine. 2022. doi:10.1097/ADM.0000000000001032.
  5. CDC State Unintentional Drug Overdose Reporting System (SUDORS). Kratom-detected deaths and polysubstance patterns. Referenced in: Gershman K, Timm K, Frank M, et al. Deaths in Colorado attributed to kratom. New England Journal of Medicine. 2019;380:97-98.
  6. Blue Ridge Poison Center, UVA Health. 7-Hydroxymitragynine Clinical Toxicology Note. August 2025. https://med.virginia.edu/toxicology/wp-content/uploads/sites/268/2025/08/Aug25-7-hydroxymitragynine.pdf
  7. Centers for Disease Control and Prevention. Trends in and Characteristics of Drug Overdose Deaths Involving Gabapentin — 23 States and DC, 2019–2020. MMWR. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098248/
  8. Alsbrook S, Pro G, Koturbash I. From kratom to 7-hydroxymitragynine: evolution of a natural remedy into a public-health threat. Pharmaceutical Biology. 2025;63:896-911. doi:10.1080/13880209.2025.2590311.
  9. U.S. Food and Drug Administration. 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat. FDA; July 2025. https://www.fda.gov/files/drugs/published/7-hydroxymitragynin_7-oh_an_assessment_of_the_scientific_data_and_toxicological_concerns_around_an_emerging_opioid_threat.pdf
  10. National Institute on Drug Abuse. Medications for Opioid Use Disorder. NIDA. Updated May 2025. https://nida.nih.gov/research-topics/medications-opioid-use-disorder
This article is for educational purposes only and is not a substitute for professional medical advice. If you are experiencing severe withdrawal symptoms, contact a healthcare provider or go to your nearest emergency room.